Scientists uncover strategy able to dramatically reduce chemotherapy's side effects
2012-08-14
(Press-News.org) Researchers in Leuven (VIB/KU Leuven) have confirmed their hypothesis that normalizing blood vessels by blocking oxygen sensor PHD2 would make chemotherapy more effective. They also demonstrated for the first time that this strategy would reduce the harmful side effects of chemotherapy on healthy organs.
Limited success of chemotherapy
The effectiveness of chemotherapy is first and foremost limited by the difficulties of delivering the anticancer drugs to the actual tumor. Tumors are characterized by abnormally shaped blood vessels – they are irregular in shape, have weak textures and easily tear. These leaking blood vessels prevent anticancer drugs from reaching tumor cells while promoting metastasis. Secondly, chemotherapy can have seriously harmful effects on healthy organs, leading even to heart and kidney failure.
Oxygen sensor (PHD2)
Earlier research at Max Mazzone's lab had already shown that reduced activity of the oxygen sensor PHD2 under hypoxic conditions resulted in a more streamlined vasculature. In this new study, and using mouse models, Rodrigo Leite de Oliveira, Sofie Deschoemaker and Max Mazzone prove their earlier hypothesis that streamlining blood flow by inhibiting PHD2 can render cancer treatments more effective. Firstly, the better formed blood vessels ensure that the anticancer drugs are distributed throughout the tumor, thus increasing their impact. They also allow for smaller doses – a significant advantage when administering toxic drugs. The researchers further proved that inhibiting PHD2 results in the production of anti-oxidant enzymes able to neutralize the harmful side effects of chemotherapy.
A first step toward increasing the effectiveness of chemotherapy
The study is promising: chemotherapy combined with specific PHD2 inhibitors would make chemotherapy more effective while reducing the harmful side effects that place such a heavy burden on patients. Unfortunately, there are no specific PHD2 inhibitors available right now, so we have a long way to go before patients will be able to benefit from this discovery.
INFORMATION:
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-08-14
TEMPE, Ariz. – Earthquakes are among the most destructive and common of geologic phenomena. Several million earthquakes are estimated to occur worldwide each year (the vast majority are too small to feel, but their motions can be measured by arrays of seismometers). Historically, most of Arizona has experienced low levels of recorded seismicity, with infrequent moderate and large earthquakes in the state. Comprehensive analyses of seismicity within Arizona have not been previously possible due to a lack of seismic stations in most regions, contributing to the perception ...
2012-08-14
Experts agree that, more than ever before, modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause untold damage. Now a Tel Aviv University researcher is suggesting that the same tactics should be employed in the battle against one of the body's deadliest enemies — cancer.
In an article published in Trends in Microbiology, Prof. Eshel Ben-Jacob of TAU's School of Physics and Astronomy and Prof. Herbert Levine of Rice University, long-time bacteria researchers, and Prof. Donald Coffey of Johns Hopkins University, a renowned ...
2012-08-14
AUGUSTA, Ga. – Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say.
Serotonin is a neurotransmitter that enables brain cells to communicate and brain-derived neurotropic factor, or BDNF, is a brain-nourishing molecule that also aids connectivity. Popular antidepressants such as Prozac, developed to increase levels of serotonin, have recently been found to also increase BDNF levels, said Dr. Anilkumar Pillai, neuroscientist at the Medical College of Georgia ...
2012-08-14
New Rochelle, NY, August 14, 2012—Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the AIDS Patient Care ...
2012-08-14
UPTON, NY - Scientists taking advantage of the versatility and new capabilities of the Relativistic Heavy Ion Collider (RHIC), an atom smasher at the U.S. Department of Energy's Brookhaven National Laboratory, have observed first glimpses of a possible boundary separating ordinary nuclear matter, composed of protons and neutrons, from the seething soup of their constituent quarks and gluons that permeated the early universe some 14 billion years ago. Though RHIC physicists have been creating and studying this primordial quark-gluon plasma (QGP) for some time, the latest ...
2012-08-14
EAST LANSING, Mich. — Soil microbes are impulsive. So much so that they help plants face the challenges of a rapidly changing climate.
Jen Lau and Jay Lennon, Michigan State University biologists studied how plants and microbes work together to help plants survive the effects of global changes, such as increased atmospheric CO2 concentrations, warmer temperatures and altered precipitation patterns. The results, appearing in the current issue of the Proceedings of the National Academy of Sciences, showed that microbes in the ground not only interact with plants, but they ...
2012-08-14
Researchers at Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory and animal experiments involving a new combination therapy for multiple myeloma, the second most common form of blood cancer.
The study published online in the journal Cancer Research details a dramatic increase in multiple myeloma cell death caused by a combination of the drugs obatoclax and flavopiridol. The researchers, led by Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational ...
2012-08-14
CAMBRIDGE, Mass. -- Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than others.
MIT researchers led by Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, have now shown that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists to ...
2012-08-14
WASHINGTON, Aug. 14, 2012-- To warn of chemical attacks and help save lives, it's vital to quickly determine if even trace levels of potentially deadly chemicals—such as the nerve gas sarin and other odorless, colorless agents—are present. U.S. Army researchers have developed a new chemical sensor that can simultaneously identify a potentially limitless numbers of agents, in real time. A paper describing the system has been published today in the Optical Society's (OSA) journal, Optics Letters.
The new system is based on a phenomenon known as the photoacoustic effect, ...
2012-08-14
URBANA – A new discovery should make the alternative fuel butanol more attractive to the biofuel industry. University of Illinois scientist Hao Feng has found a way around the bottleneck that has frustrated producers in the past and could significantly reduce the cost of the energy involved in making it as well.
"The first challenge in butanol production is that at a certain concentration the fuel being created becomes toxic to the organism used to make it (Clostridium pasteurianum and other strains), and that toxicity limits the amount of fuel that can be made in one ...
LAST 30 PRESS RELEASES:
[Press-News.org] Scientists uncover strategy able to dramatically reduce chemotherapy's side effects
